Case Study

Running a profitable, growing and sustainable business: Novo Nordisk (A)

4 pages
June 2005
Reference: IMD-2-0115

Consumer activists have published a guide, which warns consumers about the use of enzymes in laundry detergents and of genetic engineering in enzyme production. Steen Riisgaard, head of the enzyme business at Novo Nordisk, is very concerned about the impact these warnings will have on his business. Steen is concerned because about 20 years earlier Ralph Nader published similar warnings about enzymes. As a consequence of those warnings the company’s sales plummeted and Novo had to lay off 700 people in Denmark. With the concern being that similar bad experiences are heading their way, what would you advice Steen and his team to do?

Corporate Social Responsibility, Pharmaceuticals, Corporate Sustainability Management
Field Research
© 2005
Available Languages
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]


Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics